Ensysce Biosciences, Inc. — Form D
Ensysce Biosciences, Inc. of LA JOLLA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-06. The offering totals $15.9M, of which $5.3M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2021-10-06
- Form: D
- Accession: 0001493152-21-024773
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $15.9M
- Amount sold: $5.3M
- Remaining: $10.6M
- Investors: 3
- Date of first sale: 2021-09-24
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-415917
Issuer
- Name: Ensysce Biosciences, Inc.
- CIK: 0001716947
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 7946 IVANHOE AVE,, LA JOLLA, CA, 92037
- Phone: (858) 263-4196
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| D Lynn Kirkpatrick | Director | La Jolla, CA |
| D Lynn Kirkpatrick | Executive Officer | La Jolla, CA |
| David Lynn Humphrey | Executive Officer | La Jolla, CA |
| Adam Lynn Levin | Director | La Jolla, CA |
| Curtis Lynn Rosebraugh | Director | La Jolla, CA |
| Lee Lynn Rauch | Director | La Jolla, CA |
| William Lynn Chang | Director | La Jolla, CA |
| Andrew Lynn Benton | Director | La Jolla, CA |
| Steve Lynn Martin | Director | La Jolla, CA |
| Bob Lynn Gower | Director | La Jolla, CA |
Other filings by this issuer (6)
More